Hendrianus The: Intravenous Cangrelor in Hemodynamically Unstable Patients Undergoing PCI
Hendrianus The, Interventional & Structural Cardiology Fellow at Heart and Brain Hospital, Chung-Ang University Medical Center, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“I would like to share our recently published meta-analysis evaluating intravenous cangrelor in hemodynamically unstable patients undergoing PCI.
We found that IV cangrelor was associated with reduced mortality, with the most pronounced benefit observed in patients with cardiogenic shock, along with improved coronary flow.
These findings support its role as a valuable alternative when oral P2Y12 inhibitor administration is not feasible, pending confirmation in large-scale randomized trials.”
Title: Cangrelor in critically ill patients with cardiogenic shock or post-cardiac arrest undergoing percutaneous coronary intervention: a systematic review and meta-analysis
Authors: Hendrianus Hendrianus, Young-Hoon Jeong, Sang Yeub Lee, Jun Hwan Cho, Jinhwan Jo, Diana A. Gorog, Jacek Kubica, Udaya S. Tantry, Paul A. Gurbel, Sang-Wook Kim
Read the Full Article on Critical Care

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics